ABVC BioPharma, Inc. Convertible Notes Payable
ABVC BioPharma, Inc. (ABVC) had Convertible Notes Payable of $9.01 thousand as of 2025-04-05, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Notes and Loans Payable › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2026-08-12
- 2025-04-05: Convertible Notes Payable $9.01K.
- 2024-03-31: Convertible Notes Payable $872.34K.
- 2023-12-31: Convertible Notes Payable $886.52K.
- 2023-11-17: Convertible Notes Payable $1.20M.
| Period end | Convertible Notes Payable |
|---|---|
| 2025-04-05 | $9.01K 10-Q · filed 2026-08-12 |
| 2024-03-31 | $872.34K 10-Q · filed 2025-04-30 |
| 2023-12-31 | $886.52K 10-K · filed 2025-04-15 |
| 2023-11-17 | $1.20M 10-K · filed 2024-03-13 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 |
| 2021-03-31 | $66.90K 10-Q · filed 2022-05-16 |